Selected research
Market Structure
Global Liranaftate Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Liranaftate market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Liranaftate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Liranaftate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Liranaftate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Liranaftate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Liranaftate include Zenyaku Kogyo Company, Fujian Provincial Li Fei Ke Pharmaceutical Co. Ltd, Nanjing Changao Pharmaceutical Co. Ltd, Tianfang Pharmaceutical Co., Ltd, Yangzijiang Pharmaceutical Group Co. Ltd and Zhejiang Wansheng Pharmaceutical Co. Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Liranaftate market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Liranaftate and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Liranaftate revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Liranaftate market size, projected growth trends, production technologies, key applications, and end-use industries.
Liranaftate Segment by Company
Zenyaku Kogyo Company
Fujian Provincial Li Fei Ke Pharmaceutical Co. Ltd
Nanjing Changao Pharmaceutical Co. Ltd
Tianfang Pharmaceutical Co., Ltd
Yangzijiang Pharmaceutical Group Co. Ltd
Zhejiang Wansheng Pharmaceutical Co. Ltd
Liranaftate Segment by Type
Cream
Spray
Liranaftate Segment by Application
Tinea Pedis
Jock Itch
Liranaftate Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Liranaftate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Liranaftate and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Liranaftate.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Liranaftate in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Liranaftate industry.
Chapter 3: Detailed analysis of Liranaftate companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Liranaftaterevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Cream
- Spray
Applications
- Tinea Pedis
- Jock Itch
Companies covered
- Zenyaku Kogyo Company
- Fujian Provincial Li Fei Ke Pharmaceutical Co. Ltd
- Nanjing Changao Pharmaceutical Co. Ltd
- Tianfang Pharmaceutical Co., Ltd
- Yangzijiang Pharmaceutical Group Co. Ltd
- Zhejiang Wansheng Pharmaceutical Co. Ltd
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Liranaftate Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Cream
- 1.2.3 Spray
- 1.3 Market Analysis by Application
- 1.3.1 Global Liranaftate Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Tinea Pedis
- 1.3.3 Jock Itch
- 1.4 Global Market Growth Prospects
- 1.5 Global Liranaftate Growth Trends by Region
- 1.5.1 Global Liranaftate Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Liranaftate Market Size by Region (2021-2026)
- 1.5.3 Liranaftate Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Liranaftate Market Dynamics
- 2.1 Liranaftate Industry Trends
- 2.2 Liranaftate Industry Drivers
- 2.3 Liranaftate Industry Opportunities and Challenges
- 2.4 Liranaftate Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Liranaftate Revenue by Company (2021-2026)
- 3.2 Global Liranaftate Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Liranaftate Key Company Head office and Area Served
- 3.4 Global Liranaftate Company, Product Type & Application
- 3.5 Global Liranaftate Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Liranaftate Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Liranaftate Players Market Share by Revenue in 2025
- 3.6.3 2025 Liranaftate Tier 1, Tier 2, and Tier 3
4 Liranaftate Market by Type
- 4.1 Global Liranaftate Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Liranaftate Market Size by Type (2021-2032)
- 4.3 Global Liranaftate Market Size Share by Type (2021-2032)
5 Liranaftate Market by Application
- 5.1 Global Liranaftate Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Liranaftate Market Size by Application (2021-2032)
- 5.3 Global Liranaftate Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Zenyaku Kogyo Company
- 6.1.1 Zenyaku Kogyo Company Company Information
- 6.1.2 Zenyaku Kogyo Company Business Overview
- 6.1.3 Zenyaku Kogyo Company Liranaftate Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Zenyaku Kogyo Company Liranaftate Product Portfolio
- 6.1.5 Zenyaku Kogyo Company Recent Developments
- 6.2 Fujian Provincial Li Fei Ke Pharmaceutical Co. Ltd
- 6.2.1 Fujian Provincial Li Fei Ke Pharmaceutical Co. Ltd Company Information
- 6.2.2 Fujian Provincial Li Fei Ke Pharmaceutical Co. Ltd Business Overview
- 6.2.3 Fujian Provincial Li Fei Ke Pharmaceutical Co. Ltd Liranaftate Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Fujian Provincial Li Fei Ke Pharmaceutical Co. Ltd Liranaftate Product Portfolio
- 6.2.5 Fujian Provincial Li Fei Ke Pharmaceutical Co. Ltd Recent Developments
- 6.3 Nanjing Changao Pharmaceutical Co. Ltd
- 6.3.1 Nanjing Changao Pharmaceutical Co. Ltd Company Information
- 6.3.2 Nanjing Changao Pharmaceutical Co. Ltd Business Overview
- 6.3.3 Nanjing Changao Pharmaceutical Co. Ltd Liranaftate Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Nanjing Changao Pharmaceutical Co. Ltd Liranaftate Product Portfolio
- 6.3.5 Nanjing Changao Pharmaceutical Co. Ltd Recent Developments
- 6.4 Tianfang Pharmaceutical Co., Ltd
- 6.4.1 Tianfang Pharmaceutical Co., Ltd Company Information
- 6.4.2 Tianfang Pharmaceutical Co., Ltd Business Overview
- 6.4.3 Tianfang Pharmaceutical Co., Ltd Liranaftate Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Tianfang Pharmaceutical Co., Ltd Liranaftate Product Portfolio
- 6.4.5 Tianfang Pharmaceutical Co., Ltd Recent Developments
- 6.5 Yangzijiang Pharmaceutical Group Co. Ltd
- 6.5.1 Yangzijiang Pharmaceutical Group Co. Ltd Company Information
- 6.5.2 Yangzijiang Pharmaceutical Group Co. Ltd Business Overview
- 6.5.3 Yangzijiang Pharmaceutical Group Co. Ltd Liranaftate Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Yangzijiang Pharmaceutical Group Co. Ltd Liranaftate Product Portfolio
- 6.5.5 Yangzijiang Pharmaceutical Group Co. Ltd Recent Developments
- 6.6 Zhejiang Wansheng Pharmaceutical Co. Ltd
- 6.6.1 Zhejiang Wansheng Pharmaceutical Co. Ltd Company Information
- 6.6.2 Zhejiang Wansheng Pharmaceutical Co. Ltd Business Overview
- 6.6.3 Zhejiang Wansheng Pharmaceutical Co. Ltd Liranaftate Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Zhejiang Wansheng Pharmaceutical Co. Ltd Liranaftate Product Portfolio
- 6.6.5 Zhejiang Wansheng Pharmaceutical Co. Ltd Recent Developments
7 North America
- 7.1 North America Liranaftate Market Size (2021-2032)
- 7.2 North America Liranaftate Market Size by Type
- 7.2.1 North America Liranaftate Market Size by Type (2021-2026)
- 7.2.2 North America Liranaftate Market Size by Type (2027-2032)
- 7.2.3 North America Liranaftate Market Share by Type (2021-2032)
- 7.3 North America Liranaftate Market Size by Application
- 7.3.1 North America Liranaftate Market Size by Application (2021-2026)
- 7.3.2 North America Liranaftate Market Size by Application (2027-2032)
- 7.3.3 North America Liranaftate Market Share by Application (2021-2032)
- 7.4 North America Liranaftate Market Size by Country
- 7.4.1 North America Liranaftate Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Liranaftate Market Size by Country (2021-2026)
- 7.4.3 North America Liranaftate Market Size by Country (2027-2032)
- 7.4.4 North America Liranaftate Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Liranaftate Market Size (2021-2032)
- 8.2 Europe Liranaftate Market Size by Type
- 8.2.1 Europe Liranaftate Market Size by Type (2021-2026)
- 8.2.2 Europe Liranaftate Market Size by Type (2027-2032)
- 8.2.3 Europe Liranaftate Market Share by Type (2021-2032)
- 8.3 Europe Liranaftate Market Size by Application
- 8.3.1 Europe Liranaftate Market Size by Application (2021-2026)
- 8.3.2 Europe Liranaftate Market Size by Application (2027-2032)
- 8.3.3 Europe Liranaftate Market Share by Application (2021-2032)
- 8.4 Europe Liranaftate Market Size by Country
- 8.4.1 Europe Liranaftate Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Liranaftate Market Size by Country (2021-2026)
- 8.4.3 Europe Liranaftate Market Size by Country (2027-2032)
- 8.4.4 Europe Liranaftate Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Liranaftate Market Size (2021-2032)
- 9.2 China Liranaftate Market Size by Type
- 9.2.1 China Liranaftate Market Size by Type (2021-2026)
- 9.2.2 China Liranaftate Market Size by Type (2027-2032)
- 9.2.3 China Liranaftate Market Share by Type (2021-2032)
- 9.3 China Liranaftate Market Size by Application
- 9.3.1 China Liranaftate Market Size by Application (2021-2026)
- 9.3.2 China Liranaftate Market Size by Application (2027-2032)
- 9.3.3 China Liranaftate Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Liranaftate Market Size (2021-2032)
- 10.2 Asia Liranaftate Market Size by Type
- 10.2.1 Asia Liranaftate Market Size by Type (2021-2026)
- 10.2.2 Asia Liranaftate Market Size by Type (2027-2032)
- 10.2.3 Asia Liranaftate Market Share by Type (2021-2032)
- 10.3 Asia Liranaftate Market Size by Application
- 10.3.1 Asia Liranaftate Market Size by Application (2021-2026)
- 10.3.2 Asia Liranaftate Market Size by Application (2027-2032)
- 10.3.3 Asia Liranaftate Market Share by Application (2021-2032)
- 10.4 Asia Liranaftate Market Size by Country
- 10.4.1 Asia Liranaftate Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Liranaftate Market Size by Country (2021-2026)
- 10.4.3 Asia Liranaftate Market Size by Country (2027-2032)
- 10.4.4 Asia Liranaftate Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Liranaftate Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Liranaftate Market Size by Type
- 11.2.1 South America, Middle East & Africa Liranaftate Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Liranaftate Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Liranaftate Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Liranaftate Market Size by Application
- 11.3.1 South America, Middle East & Africa Liranaftate Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Liranaftate Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Liranaftate Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Liranaftate Market Size by Country
- 11.4.1 South America, Middle East & Africa Liranaftate Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Liranaftate Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Liranaftate Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Liranaftate Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst